JUL 31, 2018 10:06 PM PDT

DNA For Drug Development?

WRITTEN BY: Nouran Amin

Genetic data of individuals who were customers of DNA testing service for the purpose of understanding their ancestry and genetic history, such as the company 23andME, could now be utilized for the development of new drugs.

23andMe, the home DNA testing service, announced a 4-year deal with pharmaceutical company GlaxoSmithKline (GSK), giving the manufacturer exclusive rights to genetic data of 23andMe's customers. "I started 23andMe with the belief that by getting people interested in learning about themselves and participating in research, we would all benefit," says Anne Wojcicki, CEO of 23andMe. "Today is an important milestone in how 23andMe will be able to impact the lives of those with disease and how we will be able to improve the future of healthcare.” However, this did not happen without permission, 23andMe users were asked if they agree to participants of future scientific research, an opt-in clause that has extended into an active drug discovery research project. “Customers can opt in or out at any time if they don't wish to participate in the research,” Wojcicki wrote in a blog post. “Ideally, the partnership will accelerate the development of pharmaceutical breakthroughs and advance the company's mission of improving healthcare.”

According to a GSK announcement, the collaboration will place a focused effort on the discovery of precision medicines based purely on genetic data. More specifically, identifying patient subgroups that will likely benefit and respond to targeted treatments, as well as more efficiently recruiting patients with certain diseases to participate in clinical studies. Additionally, the announcement explained that over 80 percent of 23andMe’s customer base has agreed to participate in research. Now, a gene called LRRK2 in the first project between the collaboration of GSK and 23andMe, is being examined in the pre-clinical phase that serves as a potential way to develop new drugs for treating Parkinson's disease.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 19, 2020
Drug Discovery & Development
APR 19, 2020
FDA Approves New Drug for Breast Cancer
The US Food and Drug Administration has approved a new drug, known as tucatinib or Tuksya, as a treatment for advanced f ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Preventing Blindness in Premature Births
The premature birth of infants places them at risk for blindness because of retinopathy of prematurity (ROP). To prevent ...
APR 30, 2020
Drug Discovery & Development
APR 30, 2020
FDA to Approve Remdesivir to Fight COVID-19
A clinical trial investigating the ability of antiviral drug remdesivir to treat COVID-19 has found that it can signific ...
MAY 23, 2020
Chemistry & Physics
MAY 23, 2020
Improving the understanding of GPCRs functioning
New research reported in Current Opinion in Structural Biology combines structural and spectroscopic approaches to garne ...
MAY 28, 2020
Cannabis Sciences
MAY 28, 2020
Cannabis-Free CBD More Effective than Regular CBD
Commonly known to come from the cannabis plant or hemp, cannabidiol (CBD) can also be found in a range of other plants. ...
JUN 03, 2020
Cannabis Sciences
JUN 03, 2020
CBD Oil May Treat and Prevent Acne
Cannabidiol (CBD) is a compound found in cannabis. Known for its relaxing effects, some research also suggests that it m ...
Loading Comments...